IBDEI2TK ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,44967,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44967,1,3,0)
;;=3^Merkel Cell CA,Left Upper Eyelid,Incl Canthus
;;^UTILITY(U,$J,358.3,44967,1,4,0)
;;=4^C4A.121
;;^UTILITY(U,$J,358.3,44967,2)
;;=^5157276
;;^UTILITY(U,$J,358.3,44968,0)
;;=C4A.111^^170^2241^73
;;^UTILITY(U,$J,358.3,44968,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44968,1,3,0)
;;=3^Merkel Cell CA,Right Upper Eyelid,Incl Canthus
;;^UTILITY(U,$J,358.3,44968,1,4,0)
;;=4^C4A.111
;;^UTILITY(U,$J,358.3,44968,2)
;;=^5157274
;;^UTILITY(U,$J,358.3,44969,0)
;;=C4A.112^^170^2241^72
;;^UTILITY(U,$J,358.3,44969,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44969,1,3,0)
;;=3^Merkel Cell CA,Right Lower Eyelid,Incl Canthus
;;^UTILITY(U,$J,358.3,44969,1,4,0)
;;=4^C4A.112
;;^UTILITY(U,$J,358.3,44969,2)
;;=^5157275
;;^UTILITY(U,$J,358.3,44970,0)
;;=I78.1^^170^2242^9
;;^UTILITY(U,$J,358.3,44970,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44970,1,3,0)
;;=3^Nevus,Non-Neoplastic
;;^UTILITY(U,$J,358.3,44970,1,4,0)
;;=4^I78.1
;;^UTILITY(U,$J,358.3,44970,2)
;;=^269807
;;^UTILITY(U,$J,358.3,44971,0)
;;=L60.3^^170^2242^2
;;^UTILITY(U,$J,358.3,44971,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44971,1,3,0)
;;=3^Nail Dystrophy
;;^UTILITY(U,$J,358.3,44971,1,4,0)
;;=4^L60.3
;;^UTILITY(U,$J,358.3,44971,2)
;;=^5009236
;;^UTILITY(U,$J,358.3,44972,0)
;;=L92.1^^170^2242^4
;;^UTILITY(U,$J,358.3,44972,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44972,1,3,0)
;;=3^Necrobiosis Lipoidica NEC
;;^UTILITY(U,$J,358.3,44972,1,4,0)
;;=4^L92.1
;;^UTILITY(U,$J,358.3,44972,2)
;;=^5009462
;;^UTILITY(U,$J,358.3,44973,0)
;;=L20.81^^170^2242^8
;;^UTILITY(U,$J,358.3,44973,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44973,1,3,0)
;;=3^Neurodermatitis,Atopic
;;^UTILITY(U,$J,358.3,44973,1,4,0)
;;=4^L20.81
;;^UTILITY(U,$J,358.3,44973,2)
;;=^5009108
;;^UTILITY(U,$J,358.3,44974,0)
;;=D48.5^^170^2242^7
;;^UTILITY(U,$J,358.3,44974,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44974,1,3,0)
;;=3^Neoplasm,Skin,Uncertain Behavior
;;^UTILITY(U,$J,358.3,44974,1,4,0)
;;=4^D48.5
;;^UTILITY(U,$J,358.3,44974,2)
;;=^267777
;;^UTILITY(U,$J,358.3,44975,0)
;;=D49.2^^170^2242^6
;;^UTILITY(U,$J,358.3,44975,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44975,1,3,0)
;;=3^Neoplasm,Bone/Soft Tissue/Skin,Unspec Behavior
;;^UTILITY(U,$J,358.3,44975,1,4,0)
;;=4^D49.2
;;^UTILITY(U,$J,358.3,44975,2)
;;=^5002272
;;^UTILITY(U,$J,358.3,44976,0)
;;=L60.0^^170^2242^3
;;^UTILITY(U,$J,358.3,44976,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44976,1,3,0)
;;=3^Nail,Ingrowing
;;^UTILITY(U,$J,358.3,44976,1,4,0)
;;=4^L60.0
;;^UTILITY(U,$J,358.3,44976,2)
;;=^5009234
;;^UTILITY(U,$J,358.3,44977,0)
;;=L60.9^^170^2242^1
;;^UTILITY(U,$J,358.3,44977,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44977,1,3,0)
;;=3^Nail Disorder,Unspec
;;^UTILITY(U,$J,358.3,44977,1,4,0)
;;=4^L60.9
;;^UTILITY(U,$J,358.3,44977,2)
;;=^5009240
;;^UTILITY(U,$J,358.3,44978,0)
;;=Z91.19^^170^2242^10
;;^UTILITY(U,$J,358.3,44978,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44978,1,3,0)
;;=3^Noncompliance w/ Medical Treatment/Regimen
;;^UTILITY(U,$J,358.3,44978,1,4,0)
;;=4^Z91.19
;;^UTILITY(U,$J,358.3,44978,2)
;;=^5063618
;;^UTILITY(U,$J,358.3,44979,0)
;;=Z23.^^170^2242^5
;;^UTILITY(U,$J,358.3,44979,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44979,1,3,0)
;;=3^Need for Immunization(s)
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2TK 3789 printed Sep 23, 2025@20:11:34 Page 2
IBDEI2TK ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,44967,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,44967,1,3,0)
+4 ;;=3^Merkel Cell CA,Left Upper Eyelid,Incl Canthus
+5 ;;^UTILITY(U,$J,358.3,44967,1,4,0)
+6 ;;=4^C4A.121
+7 ;;^UTILITY(U,$J,358.3,44967,2)
+8 ;;=^5157276
+9 ;;^UTILITY(U,$J,358.3,44968,0)
+10 ;;=C4A.111^^170^2241^73
+11 ;;^UTILITY(U,$J,358.3,44968,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,44968,1,3,0)
+14 ;;=3^Merkel Cell CA,Right Upper Eyelid,Incl Canthus
+15 ;;^UTILITY(U,$J,358.3,44968,1,4,0)
+16 ;;=4^C4A.111
+17 ;;^UTILITY(U,$J,358.3,44968,2)
+18 ;;=^5157274
+19 ;;^UTILITY(U,$J,358.3,44969,0)
+20 ;;=C4A.112^^170^2241^72
+21 ;;^UTILITY(U,$J,358.3,44969,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,44969,1,3,0)
+24 ;;=3^Merkel Cell CA,Right Lower Eyelid,Incl Canthus
+25 ;;^UTILITY(U,$J,358.3,44969,1,4,0)
+26 ;;=4^C4A.112
+27 ;;^UTILITY(U,$J,358.3,44969,2)
+28 ;;=^5157275
+29 ;;^UTILITY(U,$J,358.3,44970,0)
+30 ;;=I78.1^^170^2242^9
+31 ;;^UTILITY(U,$J,358.3,44970,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,44970,1,3,0)
+34 ;;=3^Nevus,Non-Neoplastic
+35 ;;^UTILITY(U,$J,358.3,44970,1,4,0)
+36 ;;=4^I78.1
+37 ;;^UTILITY(U,$J,358.3,44970,2)
+38 ;;=^269807
+39 ;;^UTILITY(U,$J,358.3,44971,0)
+40 ;;=L60.3^^170^2242^2
+41 ;;^UTILITY(U,$J,358.3,44971,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,44971,1,3,0)
+44 ;;=3^Nail Dystrophy
+45 ;;^UTILITY(U,$J,358.3,44971,1,4,0)
+46 ;;=4^L60.3
+47 ;;^UTILITY(U,$J,358.3,44971,2)
+48 ;;=^5009236
+49 ;;^UTILITY(U,$J,358.3,44972,0)
+50 ;;=L92.1^^170^2242^4
+51 ;;^UTILITY(U,$J,358.3,44972,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,44972,1,3,0)
+54 ;;=3^Necrobiosis Lipoidica NEC
+55 ;;^UTILITY(U,$J,358.3,44972,1,4,0)
+56 ;;=4^L92.1
+57 ;;^UTILITY(U,$J,358.3,44972,2)
+58 ;;=^5009462
+59 ;;^UTILITY(U,$J,358.3,44973,0)
+60 ;;=L20.81^^170^2242^8
+61 ;;^UTILITY(U,$J,358.3,44973,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,44973,1,3,0)
+64 ;;=3^Neurodermatitis,Atopic
+65 ;;^UTILITY(U,$J,358.3,44973,1,4,0)
+66 ;;=4^L20.81
+67 ;;^UTILITY(U,$J,358.3,44973,2)
+68 ;;=^5009108
+69 ;;^UTILITY(U,$J,358.3,44974,0)
+70 ;;=D48.5^^170^2242^7
+71 ;;^UTILITY(U,$J,358.3,44974,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,44974,1,3,0)
+74 ;;=3^Neoplasm,Skin,Uncertain Behavior
+75 ;;^UTILITY(U,$J,358.3,44974,1,4,0)
+76 ;;=4^D48.5
+77 ;;^UTILITY(U,$J,358.3,44974,2)
+78 ;;=^267777
+79 ;;^UTILITY(U,$J,358.3,44975,0)
+80 ;;=D49.2^^170^2242^6
+81 ;;^UTILITY(U,$J,358.3,44975,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,44975,1,3,0)
+84 ;;=3^Neoplasm,Bone/Soft Tissue/Skin,Unspec Behavior
+85 ;;^UTILITY(U,$J,358.3,44975,1,4,0)
+86 ;;=4^D49.2
+87 ;;^UTILITY(U,$J,358.3,44975,2)
+88 ;;=^5002272
+89 ;;^UTILITY(U,$J,358.3,44976,0)
+90 ;;=L60.0^^170^2242^3
+91 ;;^UTILITY(U,$J,358.3,44976,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,44976,1,3,0)
+94 ;;=3^Nail,Ingrowing
+95 ;;^UTILITY(U,$J,358.3,44976,1,4,0)
+96 ;;=4^L60.0
+97 ;;^UTILITY(U,$J,358.3,44976,2)
+98 ;;=^5009234
+99 ;;^UTILITY(U,$J,358.3,44977,0)
+100 ;;=L60.9^^170^2242^1
+101 ;;^UTILITY(U,$J,358.3,44977,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,44977,1,3,0)
+104 ;;=3^Nail Disorder,Unspec
+105 ;;^UTILITY(U,$J,358.3,44977,1,4,0)
+106 ;;=4^L60.9
+107 ;;^UTILITY(U,$J,358.3,44977,2)
+108 ;;=^5009240
+109 ;;^UTILITY(U,$J,358.3,44978,0)
+110 ;;=Z91.19^^170^2242^10
+111 ;;^UTILITY(U,$J,358.3,44978,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,44978,1,3,0)
+114 ;;=3^Noncompliance w/ Medical Treatment/Regimen
+115 ;;^UTILITY(U,$J,358.3,44978,1,4,0)
+116 ;;=4^Z91.19
+117 ;;^UTILITY(U,$J,358.3,44978,2)
+118 ;;=^5063618
+119 ;;^UTILITY(U,$J,358.3,44979,0)
+120 ;;=Z23.^^170^2242^5
+121 ;;^UTILITY(U,$J,358.3,44979,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,44979,1,3,0)
+124 ;;=3^Need for Immunization(s)
